What Researchers Did
Researchers conducted a pilot study comparing standard therapy alone versus standard therapy combined with 10 sessions of short-duration hyperbaric oxygen therapy (HBOT) in 30 patients with diabetic foot ulcer Wagner 3-4 to assess changes in HbA1c, leukocyte count, and serum creatinine.
What They Found
HbA1c levels significantly decreased in both the standard therapy group (from 10.98% to 9.70%, p=0.006) and the combination therapy group (from 9.42% to 7.07%, p<0.001). Combination therapy additionally led to significant reductions in leukocyte count (from 13.97 x 10^3 to 9.74 x 10^3, p=0.001) and serum creatinine (from 1.29 mg/dL to 0.98 mg/dL, p=0.001), which were not observed with standard therapy alone.
What This Means for Canadian Patients
For Canadian patients with severe diabetic foot ulcers, short-duration hyperbaric oxygen therapy (HBOT) combined with standard care could potentially offer improved blood sugar control, reduced inflammation, and better kidney function markers. This approach might lead to enhanced healing and better overall health outcomes, potentially reducing complications associated with diabetic foot ulcers.
Canadian Relevance
This pilot study was conducted in Indonesia and has no direct Canadian connection.
Study Limitations
As a pilot study, its main limitations include a small sample size of 30 patients and being conducted at a single center, which limits the generalizability of the findings.